Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cutler

Showing results (301-310 of 323) with videos related to

Pageof 33
Sort By:
The New England Journal of Medicine|November 10, 2015
A Randomized Trial of Intensive versus Standard Blood-Pressure Control, Jackson T Wright, Jeff D Williamson, et al.
The New England Journal of Medicine|May 19, 2021
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control, Cora E Lewis, Lawrence J Fine, et al.
Hypertension (Dallas, Tex. : 1979)|November 10, 2021
SPRINT Revisited: Updated Results and ImplicationsJackson T Wright, Paul K Whelton, Karen C Johnson, et al.
Human Molecular Genetics|July 2, 2017
The RNA-binding protein, ZC3H14, is required for proper poly(A) tail length control, expression of synaptic proteins, and brain function in miceJennifer Rha, Stephanie K Jones, Jonathan Fidler, et al.
Nature Communications|May 8, 2026
CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trialsWallace Bourgeois, Hannah E Rice, Daniela V Wenge, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 13, 2012
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialWilliam C Cushman, Barry R Davis, Sara L Pressel, et al.
Blood|December 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AMLWallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, et al.
Nature Cancer|May 9, 2022
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemiaBrandon J Aubrey, Jevon A Cutler, Wallace Bourgeois, et al.
Cancer Discovery|November 9, 2022
Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic MalignanciesAbdullah O Khan, Antonio Rodriguez-Romera, Jasmeet S Reyat, et al.
Nature|March 16, 2023
MEN1 mutations mediate clinical resistance to menin inhibitionFlorian Perner, Eytan M Stein, Daniela V Wenge, et al.
Pageof 33

Showing results (301-310 of 323) with videos related to

Sort By:
Pageof 33
The New England Journal of Medicine|November 10, 2015
A Randomized Trial of Intensive versus Standard Blood-Pressure Control, Jackson T Wright, Jeff D Williamson, et al.
The New England Journal of Medicine|May 19, 2021
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control, Cora E Lewis, Lawrence J Fine, et al.
Hypertension (Dallas, Tex. : 1979)|November 10, 2021
SPRINT Revisited: Updated Results and ImplicationsJackson T Wright, Paul K Whelton, Karen C Johnson, et al.
Human Molecular Genetics|July 2, 2017
The RNA-binding protein, ZC3H14, is required for proper poly(A) tail length control, expression of synaptic proteins, and brain function in miceJennifer Rha, Stephanie K Jones, Jonathan Fidler, et al.
Nature Communications|May 8, 2026
CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trialsWallace Bourgeois, Hannah E Rice, Daniela V Wenge, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 13, 2012
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialWilliam C Cushman, Barry R Davis, Sara L Pressel, et al.
Blood|December 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AMLWallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, et al.
Nature Cancer|May 9, 2022
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemiaBrandon J Aubrey, Jevon A Cutler, Wallace Bourgeois, et al.
Cancer Discovery|November 9, 2022
Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic MalignanciesAbdullah O Khan, Antonio Rodriguez-Romera, Jasmeet S Reyat, et al.
Nature|March 16, 2023
MEN1 mutations mediate clinical resistance to menin inhibitionFlorian Perner, Eytan M Stein, Daniela V Wenge, et al.
Pageof 33